{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:40:00Z","timestamp":1790167200187,"version":"4.1.0"},"reference-count":62,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/mark\/1.0\/"}],"funder":[{"name":"David Durham and Jason Asher"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2021,3,4]]},"DOI":"10.1080\/14760584.2021.1886931","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T12:34:49Z","timestamp":1613565289000},"page":"235-242","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Improving pandemic preparedness through better, faster influenza vaccines"],"prefix":"10.1080","volume":"20","author":[{"given":"Matthew","family":"Newland","sequence":"first","affiliation":[{"name":"Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS), Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4256-7705","authenticated-orcid":false,"given":"David","family":"Durham","sequence":"additional","affiliation":[{"name":"Leidos Supporting the Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS), Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Asher","sequence":"additional","affiliation":[{"name":"Leidos Supporting the Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS), Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Treanor","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS), Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Seals","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS), Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben O.","family":"Donis","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS), Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS), Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33293-2"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000321"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12074"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.10.005"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6703a1"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168262"},{"key":"cit0007","volume-title":"Exploring Lessons Learned from a Century of Outbreaks: readiness for 2030: proceedings of a Workshop","author":"Bright RA","year":"2019"},{"key":"cit0008","unstructured":"Ferguson N, Laydon D, Nedjati-Gilani G, et al. Report 9: impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. In: Ferguson N, Laydon D, Nedjati-Gilani G, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College London. 2020; 10(77482):1\u201320."},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix608"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208802"},{"key":"cit0011","volume-title":"Pandemic and All-Hazards Preparedness Act (PAHPA 2006)","author":"Congress. US","year":"2006"},{"key":"cit0012","volume-title":"2017-2018 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan","author":"ASPR D","year":"2017"},{"key":"cit0013","unstructured":"Centers for Disease Control and Prevention (CDC). Interim Updated Planning Guidance on Allocating and Targeting Pandemic Influenza Vaccine during an Influenza Pandemic Atlanta, GA, US: department of Health and Human Services; 2018 [Cited 2021 Jan 19]. Available from: https:\/\/www.cdc.gov\/flu\/pandemic-resources\/national-strategy\/planning-guidance\/index.html."},{"key":"cit0014","volume-title":"Modernizing Influenza Vaccines in the U.S. to Promote National Security and Public Health In: EOP, editor","author":"Executive Office of the President. Executive Order (EO) 13887","year":"2019"},{"key":"cit0015","volume-title":"National Influenza Vaccine Modernization Strategy (NIVMS) 2020\u20132030","author":"US Department of Health and Human Services"},{"key":"cit0016","unstructured":"US Department of Health and Human Services. 2017 Update IV of the HHS Pandemic Influenza Plan. 2017 [cited 2021 Jan 18]. Available from: https:\/\/www.cdc.gov\/flu\/pandemic-resources\/pdf\/pan-flu-report-2017v2.pdf"},{"key":"#cr-split#-cit0017.1","unstructured":"US Homeland Security Council. National Strategy for pandemic influenza Implementation Plan. 2006: Government Printing Office"},{"key":"#cr-split#-cit0017.2","unstructured":"2006 [Cited 2021 Jan 18]. Available from: https:\/\/www.cdc.gov\/flu\/pandemic-resources\/pdf\/pandemic-influenza-implementation.pdf."},{"key":"cit0018","volume-title":"Centers for Disease Control and Prevention","author":"Centers for Disease Control and Prevention (CDC)","year":"2020"},{"key":"cit0019","unstructured":"Azar A. Determination that a Public Health Emergency Exists. Washington, DC: Assistant Secretary for Preparedness and Response (ASPR). 2020 [Cited 2021 Jan 18]. Available from: https:\/\/www.phe.gov\/emergency\/news\/healthactions\/phe\/Pages\/2019-nCoV.aspx."},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu1175"},{"key":"cit0021","unstructured":"Davies NG, Barnard RC, Jarvis CI, et al. Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012\/01 in England. 2020."},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy103"},{"key":"cit0023","unstructured":"Lagerwij AS, Suman S, Hintlian J, et al. L Special report: The path to vaccine profitability. 2015."},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.06.016"},{"key":"cit0025","first-page":"119","volume":"385","author":"Cox NJ","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.7916"},{"key":"cit0027","volume-title":"Report to Congress","year":"2006"},{"key":"cit0028","unstructured":"Johnson & Johnson Announces Collaboration with U.S. Department of Health and Human Services to Fight Influenza [Internet]. 2017 [Cited 2021 January 19]. Available from: https:\/\/www.jnj.com\/media-center\/press-releases\/johnson-johnson-announces-collaboration-with-us-department-of-health-and-human-services-to-fight-influenza"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.017"},{"key":"cit0030","unstructured":"Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines: zika virus vaccine (mRNA-1893) [Internet]. 2021 [Cited 2021 Jan 18]. Available from: https:\/\/investors.modernatx.com\/news-releases\/news-release-details\/moderna-provides-business-update-and-announces-three-new."},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608862"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1086\/656578"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0079-z"},{"issue":"16","key":"cit0034","first-page":"485","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.12854"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200822050-00001"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.019"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61297-5"},{"key":"cit0039","unstructured":"Collins F What a year it was for science advances. 2021 [Cited 2021 Jan 17]. Available from: https:\/\/directorsblog.nih.gov\/2021\/01\/12\/what-a-year-it-was-for-science-advances\/"},{"key":"cit0040","unstructured":"Biomedical Advanced Research and Development Authority (BARDA). BARDA\u2019s Rapidly Expanding COVID-19 Medical Countermeasure Portfolio. 2021. [Cited 2021 Jan 13]. Available from: https:\/\/www.medicalcountermeasures.gov\/app\/barda\/coronavirus\/COVID19.aspx?filter=vaccine"},{"key":"cit0041","unstructured":"Milken Institute. COVID-19 treatment and vaccine tracker [Internet]. 2021 [Cited 2021 Jan 13]. Available from: https:\/\/covid-19tracker.milkeninstitute.org\/#vaccines_intro."},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2035557"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy716"},{"key":"cit0044","volume-title":"Mitigating the Impact of Pandemic Influenza through Vaccine Innovation","year":"2019"},{"key":"cit0045","unstructured":"Assistant Secretary for Preparedness and Response (ASPR). HHS Invests in Modernizing U.S. Manufacturing Capacity for Pandemic Influenza Vaccine. 2019. News Release [Cited 2021 Jan 13]. Available from: https:\/\/www.hhs.gov\/about\/news\/2019\/12\/09\/hhs-invests-modernizing-us-manufacturing-capacity-pandemic-influenza-vaccine.html"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.074"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6020020"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.11.017"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.060"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.02.028"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.01.068"},{"key":"cit0052","unstructured":"Asher J, Clay M, Durham D. Github - HHS\/ASPR-flumodels. 2020 [Cited 2021 Jan 18]. Available from: github.com\/HHS\/ASPR-flumodels."},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.08.013"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.094"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.076"},{"key":"cit0056","first-page":"343","volume":"386","author":"Skountzou I","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169030"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)71087-4"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.12.011"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.10.032"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.25.20219212"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2021.1886931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T16:05:21Z","timestamp":1620230721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2021.1886931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,4]]}},"alternative-id":["10.1080\/14760584.2021.1886931"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2021.1886931","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}